Related Experiment Video

Updated: Oct 21, 2025

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.2K

Immune checkpoint inhibitor sensitivity of DNA repair deficient tumors

Pauline Rochefort1, Françoise Desseigne1, Valérie Bonadona2

  • 1Department of Medical Oncology, Centre Léon Bérard, 69008, Lyon, France.

Immunotherapy
|September 8, 2021
PubMed

Insights

Tumors with DNA repair deficiencies may respond to immune checkpoint inhibitors. This review examines clinical studies investigating this potential treatment strategy for cancer patients.

Area of Science:

  • Genetics and Molecular Biology
  • Oncology
  • Immunology

Background:

  • Faithful DNA replication is crucial for genome stability, involving multiple repair pathways.
  • Defects in DNA repair mechanisms can lead to DNA damage accumulation and cancer development.
  • Preclinical evidence suggests a link between DNA repair deficiency and sensitivity to immune checkpoint inhibitors.

Purpose of the Study:

  • To review clinical studies evaluating immune checkpoint inhibitors in patients with tumors exhibiting DNA repair deficiencies.
  • To explore the therapeutic potential of immunotherapy in the context of DNA repair defects.

Main Methods:

  • Systematic review of clinical trial data.
  • Analysis of studies focusing on immune checkpoint inhibitor efficacy.
  • Inclusion of research on tumors with specific DNA repair pathway alterations.

Main Results:

  • Clinical studies indicate varying responses to immune checkpoint inhibitors in tumors with DNA repair deficiencies.
  • Specific DNA repair pathway alterations may correlate with differential treatment outcomes.
  • Further research is needed to fully elucidate the predictive value of DNA repair status.

Conclusions:

  • Tumors with DNA repair deficiencies represent a potential target population for immune checkpoint inhibitor therapy.
  • Understanding DNA repair mechanisms is critical for optimizing cancer immunotherapy strategies.
  • Clinical investigation into DNA repair-deficient tumors and immunotherapy is ongoing and promising.
Keywords:
BRCADNA repair deficiencybiomarkercancerimmune checkpoint inhibitorsimmunotherapymicrosatellite instability

More Related Videos

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

Published on: February 24, 2023

1.9K
Visualization of DNA Repair Proteins Interaction by Immunofluorescence07:55

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

10.5K

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.8K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
4.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K